Provides fast relief to menopausal symptoms, such as hot flushes, headaches and sleep disturbances
Increases bone mineral density and leads to new bone formation.
Relieves vaginal dryness (atrophy).
Does not affect the breast and uterus, and does not affect clotting. Femarelle is not a hormone and is not perceived in the body as a hormone.
Femarelle is clinically proven SERM (Selective Estrogen receptor modulator) that was shown to relieve menopausal symptoms and promote bone health without affecting the sensitive tissues of the breast and uterus.
Clinical studies show that Femarelle provides fast acting relief, alleviating menopausal symptoms, such as hot flushes, headaches, sleep disturbances and joint and muscle discomfort, within the first month of use. Femarelle was also shown to relieve vaginal dryness and to increase bone mineral density through a unique bone forming mechanism of osteoblast activation, leading to new bone formation. This mechanism provides bone strength and maintains long term bone health. In addition to the proven efficacy, studies also demonstrate the safety of Femarelle. Since Femarelle acts as a SERM, it is able to target various parts of the body, relieving menopausal symptoms and promoting bone health, while having no effect on breast and uterine tissue. Femarelle has also been proven not to effect o clotting.